GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human IL-17A cytokine in complex with macrocycle

Analyse Crystal structure of human IL-17A cytokine in complex with macrocycle in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8CDG
Type
protein
Length
189 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.9
Source
Homo sapiens
Molecule
Interleukin-17A
UniProt
Q16552
Ligands
UTF
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · resolution 2.9 · 2 distinct chains · 0% helix, 61% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInterleukin-17Aprotein960% helix, 61% strandQ16552
BInterleukin-17Aprotein930% helix, 60% strandQ16552

Ligands and binding sites

  • UTF · (9~{S},12~{R},19~{S})-9-[[4-[[(2~{S})-2-cyclohexyl-2-(2-phenylethanoylamino)ethanoyl]amino]phenyl]methyl]-12-methyl-7,10,13,21-tetrakis(oxidanylidene)-8,11,14,20-tetrazaspiro[4.17]docosane-19-carboxylic acid · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14840.700.7949UTF
21190.460.7819empty

Interfaces

1 interface between chains.

  • A–B · 2110 Ų buried · 38 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • Q16552 · AlphaFold monomer V2.0 prediction for interleukin-17A (Q16552) · a predicted model of the same protein · chain B against A, TM-score 0.87

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.